Form 4: LifeStance Health Director Acquires Shares

Teresa DeLuca, a Director at LifeStance Health Group, Inc., acquired 17,746 restricted stock units on July 2, 2026.

Summary

• Teresa DeLuca, a Director at LifeStance Health Group, Inc. (LFST), acquired 17,746 restricted stock units (RSUs) on July 2, 2026.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• Following this transaction, DeLuca beneficially owns 125,034 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction related to compensation rather than a significant strategic event or financial performance indicator.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 17,746 RSUs indicates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of RSUs by a director, are common in the healthcare services sector as a means of executive compensation and aligning management interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting confidence in the company's value.

Key Dates

Keywords

LifeStance Health, LFST, Form 4, Insider Transaction, Restricted Stock Units, Teresa DeLuca, Beneficial Ownership